Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lancaster Resources Inc. LANRF


Primary Symbol: C.LCR

Metals & Mining
Lancaster Resources Inc. is a Canada-based company engaged in exploring lithium and uranium and other critical minerals. The Company’s Alkali Flat Lithium Project, which covers approximately 5,200 acres in Lordsburg, New Mexico, United States, and is involved in the exploration of a below-surface lithium brine target. The Company holds a 100% interest in the Catley Lalk and Centennial East... see more

Recent & Breaking News (CSE:LCR)

NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

Newsfile March 9, 2021

Psilocybin Could Help Curb Cravings and Shut Off Appetite

Livemoney March 2, 2021

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Newsfile March 2, 2021

Forget Cannabis - Psilocybin May be the Next Big Opportunity

Livemoney February 24, 2021

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial

Newsfile February 24, 2021

NeonMind (CSE:NEON) submits applications to Health Canada for product formulas to fight stress

Brieanna McCutcheon  February 10, 2021

The Top Reasons Consumer Demand for Functional Mushrooms is on the Rise

Livemoney February 10, 2021

NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress

Newsfile February 10, 2021

The Top Five Reasons Investors Are Pushing into Psychedelics

Livemoney January 27, 2021

NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

Newsfile January 27, 2021

Nature's Appetite Suppressant Could Help Millions Battling Obesity

Livemoney January 20, 2021

NeonMind Lists on the Frankfurt Stock Exchange

Newsfile January 19, 2021

Better Plant Affiliate NeonMind Lists on the Frankfurt Stock Exchange

Newsfile January 19, 2021

Psilocybin Could be the Next Big Treatment Option for Obesity

Livemoney January 14, 2021

NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

Newsfile January 14, 2021

New Psychedelics Studies Could Shed Light on Treatment for Obesity Epidemic

Livemoney January 12, 2021

NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

Newsfile January 12, 2021

NeonMind Announces Grants Pursuant to Stock Option Plan

Newsfile January 11, 2021

NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

Newsfile January 7, 2021

Psychedelics Legalization Efforts Quickly Gaining Momentum

Livemoney January 7, 2021